Professional Documents
Culture Documents
Progress Notes
1 CA Cervix
3 CA Endometrium
7 Ectopic
Pregnancy
9 Molar Pregnancy
10 UV Prolapse
1
fi
fl
CA Cervix SNI
carried out to con rm your • Cytology from the swab used as a rst
diagnosis and plan further line detection test.
management?
• Then the following assessment are indicated.
• Punch biopsy
• Wedge biopsy
• Ring biopsy
• Cone biopsy
• Conization of cervix
Staging workup
• PET scan
1
fi
fi
fi
fi
What treatment you will LLETZ or cone biopsy Management of cervical
offer the patient according cancer depends on the
to her stage of disease? Large loop excision of the transitional zone. stage and the individual
situation. The usual
treatments are:
• Cervical
intraepithelial
neoplasia and early-
stage 1A: LLETZ or
cone biopsy
• Stage 1B – 2A:
Radical
hysterectomy/
trachelectomy and
removal of local
lymph nodes with
chemotherapy and
radiotherapy
• Stage 2B – 4A:
Chemotherapy and
radiotherapy
• Stage 4B:
Management may
involve a
combination of
surgery,
radiotherapy,
chemotherapy and
palliative care
2
CA Ovary SNI
• Obesity
• Smoking
• Pelvic radiation
Justify the investigations The initial investigations in primary or
you will advise to con rm secondary care are:
the diagnosis.
• CA125 blood test (>35 IU/mL is signi cant)
• CEA
• B HCG
• CP
• Urea
• Creatinine
• Elctrolytes
• LFTs
• RFTs
• Viral serology
• Pelvic ultrasound
Staging
• MRI/PET scan
1
fl
fi
fi
Give the management plan Ovarian cancer will be managed by a specialist
for her gynaecology oncology MDT. It usually involves a
combination of surgery and chemotherapy.
Metastasis 1
Ascities 1
1 for 1 nding
Premanupausal 1
CA 125 levels.
diagnosis?
How will you investigate The initial investigations in primary or
the patient? secondary care are:
• Pelvic ultrasound
2
fi
fi
fi
fi
fi
fi
fi
fl
fi
fi
What risk factors can you
identify in her for this
condition?
Justify the investigations
you will advise to con rm
the diagnosis.
How will you manage her?
3
fi
CA Endo SNI
• Late menopause
• No or fewer pregnancies
• Obesity
• Tamoxifen
What further There are three investigations to remember
investigations are required for diagnosing and excluding endometrial
to con rm the diagnosis? cancer:
• Transvaginal ultrasound for endometrial
thickness (normal is less than 4mm
post-menopause)
• Stage IV
• Radiotherapy
• Chemoradiotherapy
Hormone therapy
• If possible debulking
1
fi
fi
Endometriosis SNI
• Bimanual examination
• Fixed uterus
• Tenderness
CA125
CT/MRI
Surgical management options:
• Laparoscopic surgery
to excise or ablate the endometrial tissue
and remove adhesions (adhesiolysis)
• Presaccral neurectomy
• Hysterectomy
• TAH and BSO
1
fi
fi
fi
fi
fi
How will you evaluate both
partners to reach a nal
diagnosis?
What are the management
options available for the
female partner if no
abnormality is detected in
male partner?
2
fi
fi
fi
fi
PCOS SNI
• Testosterone - raised
• Follicle-stimulating hormone
• Thyroid-stimulating hormone
• Pelvic Ultrasound
1
fi
Outline the steps of • General management
management for this
patient? • Weight loss - Orlistat can be used if BMI>
30.
• Calorie-controlled diet
• Exercise
• Smoking cessation
• Management of Infertility
• Weight loss
• Clomifene
• Hirsutism
• Weight loss
• Co-cyprindiol (Dianette)
• Electrolysis
• Spironolactone (mineralocorticoid
antagonist with anti-androgen e ects)
• Management of acne
• Cyclical progestogens
• Cardiovascular disease
• Advanced atherosclerosis
• Ovarian CA
• Breast CA
• Metabolic syndrome
• Sexual problems
• Infertility
2
fl
ff
ff
What is your provisional
diagnosis?
What criteria is used for The Rotterdam criteria are used for making a
the diagnosis of this diagnosis of PCOS. A diagnosis requires at least
condition? two of the three key features:
• Amenorrhoea
• Oligomenorrhoea
• Hyperandrogenism
• Hirsutism
• Acne
• Hair loss
• Obeisity
• LATE
• Acanthosis nigricans
• Cardiovascular disease
• Advanced atherosclerosis
• Ovarian CA
• Breast CA
• Metabolic syndrome
• Sexual problems
• Infertility
3
fi
Describe the drugs used • OVULATION INDUCTION
• Clomiphene citrate
• Tamoxifen
• Letrozole
• Dopamine agonists
• Bromocriptine
• Cabergoline
• Gonadotrophins
• HMG
• GnRH analogues
4
Heavy Menstrual Bleeding SNI
• Swabs/ endometrial
sampling(Diagnostic test) if there is
evidence of infection (e.g. abnormal
discharge or suggestive sexual history)
• Coagulation screen if there is a family
history of clotting disorders or periods have
been heavy since menarche
• Ferritin if they are clinically anaemic
• Thyroid function tests if there are
additional features of hypothyroidism
1
fl
fi
fi
fl
fi
fi
ff
fi
fi
fi
fi
Outline the steps of Start by excluding underlying pathology.
• Fibroids
2
ff
fi
fi
fi
fi
fi
fi
fl
A 46 years old lady presented in gynae OPD
with complaint of heavy menstrual bleeding
for the last 8 months. On examination she is
pale, pulse is 90/min. Her abdominal
examination revealed soft non tender
abdomen. On pelvic examination uterus is
normal size and adnexa are clear. Pelvic
ultrasound revealed normal uterus with no
other pelvic pathology.
What is you provisional
diagnosis?
How will you evaluate the
patient?
What are the management
options available for the
patient?
3
Ectopic Pregnancy SNI
• Laparoscopy
• Colpocentesis/colpotomy
• Serum progesterone
1
fl
fi
fl
fl
What management options Perform a pregnancy test in all women with
are available for her? abdominal or pelvic pain that may be caused by
an ectopic pregnancy. Women with pelvic pain or
tenderness and a positive pregnancy test need to
be referred to an early pregnancy assessment
unit (EPAU) or gynaecology service.
• Expectant management (awaiting
natural termination)
• Medical management (methotrexate)
• Surgical
management (salpingectomy or salpin
gotomy)
Methotrexate is highly teratogenic (harmful to
pregnancy). It is given as an intramuscular
injection into a buttock.
Surgical Management
Laparoscopic salpingectomy
Laparoscopic salpingotomy
2
fi
fi
How will you manage the Management to stabilise the patient involves:
case if on day 4 of her
medical management she • Resuscitation with an ABCDE approach
suddenly collapses with
vitals of puise, 120/min, BP • Lie the woman at, keep her warm and
60/40 mmH and communicate with her and the partner
ultrasound showing free
uid in pelvis? • Insert two large-bore cannulas
3
fl
fl
fl
fi
fl
fi
fl
Discuss your management
plan?
What are the risk factors
of this condition? • Previous ectopic pregnancy
• Previous pelvic in ammatory disease
• Previous surgery to the fallopian tubes
• Intrauterine devices (coils)
• Older age
• Smoking
What are the • Tubal Rupture
• Abdominal pregnancy
• Appendicitis
Spontaneous miscarriage
• Sub-serous broid
Sub serous broid
• GIT & Urinary tract problems
Describe investigations
required to con rm the
diagnosis.
How will you manage if
missed miscarriage is
con rmed?
4
fi
fl
fi
fi
fl
fi
fl
Fibroids SNI
Hysterosalpingography
• Danazole
• Endometrial ablation
• Resection with hysteroscopy
• Hysterectomy
• Myomectomy
• Hysterectomy
Myomectomy
• Infertility
• Intestinal obstruction
• Recurrence
• Dermatologic Manifestations of
Neurilemmoma (Schwannoma)
• Mastocytosis
How will you investigate
her?
What are the management
options?
1
fi
fi
fi
fi
fi
fi
fi
fi
fi
fi
fi
fi
fi
fi
fi
fi
fi
A 28 years old pulliparous patient has
reported in OPD with history of heavy
menstrual-bleeding, lower abdominal
heaviness, and frequency of micturition for
last lo6 month. She recently got married and
is concerned about her fertility. On
examination she is pale and there is a 16
weeks size mass in hypogastrium arising
from pelvis, rm in consistency, and non-
tender, mobile, smooth and regular margins.
On biranual examination the mass seems to
be uterine in origin and bilateral adnexa are
clear.
What is your provisional
diagnosis?
How will you di erentiate
between an ovarian and a
uterine mass on clinical
grounds?
Justify one investigation
that will help you to
con rm your diagnosis.
What options of treatment
will you o er your patient?
Enlist complications that
you will anticipate if she
opts for surgical
management.
2
fi
ff
fi
ff
Molar Pregnancy SNI
Laboratory studies
• Thyroxine level
1
fi
fi
fi
fi
fi
What are the risk fastors • Mother's age
• Ethnicity
• History of OCP
• IUD
• Blood group
• Radiation
• Socioeconomic status
• Infertility
Missed miscarriage
F
Menohhragea
P4
V
Fibroids
Polyhydraminios
Preeclampsia
Threatened miscarriage
Vomiitng
Investigations to con rm
molar pregnancy
Rx if molar
2
fi
fi
fi
fi
UV Prolapse SNI
Conservative management
• Physiotherapy
• Weight loss
• Lifestyle changes for associated stress
incontinence, such as reduced caffeine
intake and incontinence pads
• Treatment of related symptoms, such as
treating stress incontinence with
anticholinergic mediations
• Vaginal oestrogen cream
Vaginal pessaries
• Shelf
• Cube
• Donut
• Hodge
Surgery
1
ffi
fi
ff
fi
ff
ffi
fi
Note on Grades of UV The severity of a uterine prolapse can be graded
prolapse using the pelvic organ prolapse
quanti cation (POP-Q) system:
• Grade 0: Normal
• Grade 1: The lowest part is more than 1cm
above the introitus
• Grade 2: The lowest part is within 1cm of
the introitus (above or below)
• Grade 3: The lowest part is more than 1cm
below the introitus, but not fully descended
• Grade 4: Full descent with eversion of the
vagina
2
fi
Miscarriage SNI
• DIC pro le
• Urineanalysis
• Cultures
• Blood
• Urine
• Imaging
• Ultrasound studies
• Procedural
• D and C
Outline the management Less Than 6 Weeks Gestation
plan
Women with a pregnancy less than 6 weeks’
gestation presenting with bleeding can be
managed expectantly provided they have no
pain and no other complications or risk factors
Expectant Management
Medical Management
• Heavier bleeding
• Pain
• Vomiting
• Diarrhoea
Surgical Management
1
fi
fi
fi
fi
fi
What are the long term Infertility
Renal failure
Ectopic pregnancy
Hydatid mole
How will you manage if There are two options for surgical management
incomplete miscarriage is of a miscarriage:
diagnosed
• Manual vacuum aspiration
• Electric vacuum aspiration
2
Sub fertility SNI
partners? • Hx of smoking
• WIFE
1
fi
How will you evaluate this Initial investigations, often performed in primary HISTORY
• Speci c to female -
Menstrual Hx, Hx
Female hormone testing involves: of PID, previous
fertility Rx, Cervical
smear Hx
• Anti-Mullerian hormone
• Thyroid function tests when • Female - GPE,
symptoms are suggestive Abdominal
• Prolactin (hyperprolactinaemia is a examination, Pelvic
examination
• Genetic testing
Assessment of ovarian
• Further imaging, such as transrectal Reserve -
FSH
TUBAL FACTORS
Hysterosalpingography
Radio–opaque dye
(urogra n) is used
Laparoscopy
◦ Co-existing pelvic
pathology can also be
UTERINE FACTORS
Hysterosalpingography -
Intrauterine adhesions,
Submucous broids, uterine
malformation can
be detected.
Hysteroscopy
MALES
o Karyotyping
o Testicular Biopsy
Antisperm Antibodies:
2
fi
fi
ffi
fl
fi
ffl
Outline the management • MEDICAL MANAGEMENT
• Antiestrogen drugs
• Clomiphene citrate
• Tamoxifen
• Letrozole
• Dopamin agonists
• Bromocriptine
• Cabergoline
• Gonadotrophins
• HMG
• GnRH analogues
• Intrauterine Insemination
• In vitro fertilization
• SURGICAL TREATMENT
• OTHER OPTIONS
• Surrogacy
• Adoption
3
fi
MP and HRT SNI
• Oestrogen and progesterone levels are
low
• LH and FSH levels are high, in response
to an absence of negative feedback from
oestrogen
What other side e ect she • Hot ushes 7 dwarfs of menopause
Bloated
1
ff
fi
fl
fl
fi
fi
ff
fl
Adenomyosis SNI
1
STIs SNI